Skip to content

H2020FP7HORIZON

Novartis Pharma AG

Country
CHSwitzerland
Defence projects
0
Projects, all programmes
85
As coordinator
8
EU contribution (CORDIS)
EUR 2,998,017
Active
2008 to 2025

Projects

85 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
AEGISAccelerated Early staGe drug diScoveryH20202016ParticipantEUR 265,227
ROADMAPReal world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020H20202016ParticipantEUR 0
CaSR BiomedicineCalcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable DiseasesH20202016PartnerEUR 0
EPADEuropean Prevention of Alzheimer’s Dementia ConsortiumFP72015ParticipantNot stated
INNODIATranslational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797H20202015ParticipantEUR 0
ADAPT-SMARTAccelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890H20202015ParticipantEUR 0
CHESSConnected Health Early Stage Researcher Support SystemH20202015PartnerEUR 0
NABBADesign and development of advanced NAnomedicines to overcome Biological BArriers and to treat severe diseasesH20202015PartnerEUR 0
IABC PROGRAMMEiABC ProgrammeFP72015CoordinatorNot stated
IPIEIntelligent Assessment of Pharmaceutical in the EnvironmentFP72015ParticipantNot stated
ULTRA-DDUnrestricted Leveraging of Targets for Research Advancement and Drug DiscoveryFP72015CoordinatorNot stated
WEB-RADRRecognising Adverse Drug ReactionsFP72014CoordinatorNot stated
AETIONOMYAetionomy – Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and TherapyFP72014ParticipantNot stated
SPRINTTSarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategiesFP72014ParticipantNot stated
EARIPEuropean Asthma Research and Innovation PartnershipFP72013ParticipantNot stated
GETREALIncorporating real-life clinical data into drug developmentFP72013ParticipantNot stated
ADVANCEAccelerated Development of Vaccine benefit-risk Collaboration in EuropeFP72013ParticipantNot stated
EUPATIEuropean Patients' Academy on Therapeutic InnovationFP72012ParticipantNot stated
ABIRISKAnti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the riskFP72012CoordinatorNot stated
MEDIASRESNovel Statistical Methodology for Diagnostic/Prognostic and Therapeutic Studies and Systematic ReviewsFP72012ParticipantEUR 528,884

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.